Markets:

Overview

News

Currencies

International

Treasuries

NovoCure Limited - Ordinary Shares (NQ:NVCR)

17.45 +0.80 (+4.80%)

Streaming Delayed Price Updated: 3:32 PM EDT, Jun 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NovoCure Limited - Ordinary Shares

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

20 21 Next >

3 Top Stocks to Buy Hand Over Fist Before the End of 2022 ↗

December 12, 2022

You probably shouldn't wait for long to buy these stocks.

Via The Motley Fool

5 Top Stocks for December ↗

December 04, 2022

From game-changing products to indisputable growth catalysts, this list of top stocks has something for all.

Via The Motley Fool

12 Top Stocks to Buy in December ↗

December 03, 2022

Add this dandy dozen to your stocking this month.

Via The Motley Fool

Where NovoCure Stands With Analysts ↗

November 29, 2022

Via Benzinga

Why Novocure Stock Is Jumping Today ↗

November 29, 2022

Novocure's innovative cancer therapy picked up a big win in Canada.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2022 ↗

November 29, 2022

Via Benzinga

5 Analysts Have This to Say About NovoCure ↗

November 29, 2022

Via Benzinga

Novocure’s Optune® Approved in Canada for the Treatment of Newly Diagnosed and Recurrent Glioblastoma

November 29, 2022

From Novocure

Via Business Wire

FedEx To Rally Over 25%? Here Are 10 Other Price Target Changes For Tuesday ↗

November 29, 2022

Keybanc lowered Salesforce, Inc. (NYSE: CRM) price target from $210 to $200. . Keybanc analyst Michael Turits maintained an Overweight rating on the stock. Salesforce shares gained 0.5% to $154.45 in...

Via Benzinga

3 Growth Stocks to Buy That Could Skyrocket ↗

November 28, 2022

The future looks promising for all three of these stocks.

Via The Motley Fool

Novocure Stock: Bull vs. Bear ↗

November 26, 2022

The company's technology has a lot of potential. But does its stock?

Via The Motley Fool

Novocure to Participate in 34th Annual Piper Sandler Healthcare Conference

November 23, 2022

From Novocure

Via Business Wire

What 4 Analyst Ratings Have To Say About NovoCure ↗

October 28, 2022

Analysts have provided the following ratings for NovoCure (NASDAQ:NVCR) within the last quarter:

Via Benzinga

Novocure Announces 25 Abstracts on Tumor Treating Fields Therapy at Society for Neuro-Oncology 2022 Annual Meeting

November 17, 2022

From Novocure

Via Business Wire

Novocure Opens Office in Montreal to Expand and Support Growing Business in Canada

November 15, 2022

From Novocure

Via Business Wire

Novocure Secures CE Mark for New Array

November 11, 2022

From Novocure

Via Business Wire

Where NovoCure Stands With Analysts ↗

October 28, 2022

NovoCure (NASDAQ:NVCR) has observed the following analyst ratings within the last quarter:

Via Benzinga

Novocure (NVCR) Q3 2022 Earnings Call Transcript ↗

October 27, 2022

NVCR earnings call for the period ending September 30, 2022.

Via The Motley Fool

Why Novocure Stock Is Sinking Today ↗

October 24, 2022

An analyst's downgrade is weighing on the biotech company.

Via The Motley Fool

2 Potentially Explosive Stocks to Buy in November ↗

November 08, 2022

Both Novocure and MercadoLibre could have good news on the way.

Via The Motley Fool

NovoCure's Return On Capital Employed Insights ↗

November 02, 2022

NovoCure (NASDAQ:NVCR) brought in sales totaling $131.00 million during Q3 according to data provided by Benzinga Pro. However, earnings decreased 10.7%, resulting in a loss of $26.58 million.

Via Benzinga

3 Unstoppable Stocks That Could Double in 5 Years ↗

October 29, 2022

The opportunities for these innovators are tremendous.

Via The Motley Fool

NovoCure: Q3 Earnings Insights ↗

October 27, 2022

NovoCure (NASDAQ:NVCR) reported its Q3 earnings results on Thursday, October 27, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings NovoCure beat estimated earnings...

Via Benzinga

Novocure Reports Third Quarter 2022 Financial Results

October 27, 2022

From Novocure

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2022 ↗

October 24, 2022

Upgrades

Via Benzinga

CSX To Rally 20%? Here Are 5 Other Price Target Changes For Monday ↗

October 24, 2022

Raymond James raised CSX Corporation (NASDAQ: CSX) price target from $31 to $33. Raymond James analyst Patrick Tyler Brown maintained the stock with an Outperform rating. CSX shares rose 1.7% to close...

Via Benzinga

Novocure Announces 11 Presentations on Tumor Treating Fields in Multiple Solid Tumor Types at the American Society for Radiation Oncology 2022 Annual Meeting

October 21, 2022

From Novocure

Via Business Wire

Novocure Announces Review Article of Anti-Cancer Mechanisms of Action of Tumor Treating Fields Published in Journal of Molecular Cell Biology

October 20, 2022

From Novocure

Via Business Wire

Novocure Launches Campaign to Drive Awareness and Understanding of Tumor Treating Fields Therapy

October 20, 2022

From Novocure

Via Business Wire

3 Unstoppable Stocks You Can Buy Now for Less Than $100 ↗

October 13, 2022

They might not be available so cheaply for too much longer.

Via The Motley Fool

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.